rs1049504575
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015346.4(ZFYVE26):c.7128+2T>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015346.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFYVE26 | NM_015346.4 | c.7128+2T>A | splice_donor_variant, intron_variant | ENST00000347230.9 | NP_056161.2 | |||
ZFYVE26 | XM_047431173.1 | c.7128+2T>A | splice_donor_variant, intron_variant | XP_047287129.1 | ||||
ZFYVE26 | XM_047431174.1 | c.4803+2T>A | splice_donor_variant, intron_variant | XP_047287130.1 | ||||
ZFYVE26 | XM_047431175.1 | c.4710+2T>A | splice_donor_variant, intron_variant | XP_047287131.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251372Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135846
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 06, 2023 | This sequence change affects a donor splice site in intron 38 of the ZFYVE26 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (no rsID available, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with hereditary spastic paraplegia (PMID: 19805727). ClinVar contains an entry for this variant (Variation ID: 551226). Studies have shown that disruption of this splice site results in skipping of exon 38 and introduces a premature termination codon (PMID: 19805727). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Hereditary spastic paraplegia 15 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 12, 2021 | NM_015346.3(ZFYVE26):c.7128+2T>A is a canonical splice site variant classified as likely pathogenic in the context of spastic paraplegia type 15. c.7128+2T>A has been observed in a case with relevant disease (PMID: 19805727). Functional assessments of this variant are available in the literature (PMID: 19805727). c.7128+2T>A has been observed in population frequency databases (gnomAD: NFE 0.001%). In summary, NM_015346.3(ZFYVE26):c.7128+2T>A is a canonical splice site variant in a gene where loss of function is a known mechanism of disease, is predicted to disrupt protein function, and has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at